Eden Bioscience (EDEN) Announces Resignation of President/CFO
More News related to EDEN
- Eden Bioscience (EDEN) to Deregister Common Stock & Liquidate
- Eden Bioscience Announces Voluntary Delisting From Nasdaq and Filing of Articles of Dissolution
- Eden Bioscience Announces Shareholders' Approval of Plan of Dissolution and Liquidation
- Eden Bioscience (EDEN) Announces Resignation of President/CFO
- Eden Bioscience (EDEN) Effects 1-for-3 Reverse Stock Split
Eden Bioscience Corporation (Nasdaq: EDEN) announced that President and Chief Financial Officer Bradley S. Powell will resign from the Company effective as of September 30, 2008, to pursue another career opportunity. The Board of Directors will be conducting a search for a potential candidate to fill these positions.
(NOTE - Shares trade under $2 and current market cap is less than $5 million)
Eden Bioscience Corporation (Eden Bioscience) sells harpin protein-based products for the protection of plants and seeds, and the promotion of overall plant health.[SM]
Related Categories
Management ChangesStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
